Kytopen Company
Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.
Connections from
Last Funding Type:
Series A
Funding Status:
Early Stage Venture
Headquarters:
Cambridge, Massachusetts, United States
Industry:
Gene therapy
Total Funding:
36095000
Employee Number:
11-50
Founded Date:
1/1/2017